Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00577876 · ClinicalTrials.gov registry record · NA
Assessment of the Functional Significance of Accessory Pudendal Arteries
A NA study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT00577876: Completed NA study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00577876 is a NA study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 38 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00577876, a NA study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
For patients with Prostate Cancer advances in medical technology have enabled us to identify "accessory" (additional) pudendal arteries (called APA) while performing a laparoscopic radical prostatectomy (a scope with a video camera is used during the surgery). APAs running near the prostate gland are identified in approximately 1 in 3 to 4 patients. However, large APAs, like the ones looked for in this study, are identified in 15-18% of all patients. These arteries are preserved more than 80% of the time, depending on their size and location.With this study, we plan to evaluate whether APAs supply blood to the penis and male erections, as well as the amount supplied.
Interventions
- PROCEDURE Trimix Injection with Doppler Ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2006-09 |
| Est. Completion | 2011-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00577876
The ClinicalTrials.gov registry entry for NCT00577876 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Trimix Injection with Doppler Ultrasound is the first listed.
NCT00577876 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00577876 about?
NCT00577876 is a clinical study titled "Assessment of the Functional Significance of Accessory Pudendal Arteries". For patients with Prostate Cancer advances in medical technology have enabled us to identify "accessory" (additional) pudendal arteries (called APA) while performing a laparoscopic radical prostatectomy (a scope with a video camera is used during the surgery). APAs running near the prostate gland ar...
What is the current status of trial NCT00577876?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2006-09. Estimated completion is 2011-10.
What interventions are being tested in trial NCT00577876?
The interventions under investigation include: Trimix Injection with Doppler Ultrasound (PROCEDURE).
Who is sponsoring clinical trial NCT00577876?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.